Product Code: ETC367704 | Publication Date: Aug 2022 | Product Type: Market Research Report | |
Publisher: 6Wresearch | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
The India nuclear imaging market import shipment demonstrated a robust growth trend with a notable CAGR from 2020-2024. The growth rate between 2023 and 2024 accelerated even further, indicating a significant momentum in market expansion. The market showed a clear upward trajectory, reflecting a strong and dynamic performance during the period.
The India Nuclear Imaging Market size was valued at USD 46 million in 2017, and it is projected to register a CAGR of 10% due to increasing preference for nuclear imaging technology among healthcare professionals owing to its wide range of applications from cancer detection & screening therapies to cardiovascular diseases treatments assessment capabilities. Furthermore, rapid technological advancements that are contributing to the upgradation in nuclear imaging equipment?s performance have been providing impetus towards upsurge demand for nuclear imaging systems across hospitals & diagnostic clinics.
The nuclear imaging market in India is witnessing substantial growth, driven by several factors. One of the key drivers is the increasing prevalence of chronic diseases such as cancer and cardiac disorders, which require accurate and early diagnostic imaging for effective treatment planning. Nuclear imaging techniques, such as PET (Positron Emission Tomography) and SPECT (Single-Photon Emission Computed Tomography), provide valuable insights into the functioning of organs and tissues, enabling early disease detection and monitoring. Additionally, the growing geriatric population and the rising awareness about preventive healthcare have led to an increased demand for nuclear imaging services in India. Technological advancements in nuclear imaging systems, such as the development of hybrid imaging technologies that combine PET and CT (Computed Tomography) or SPECT and CT, have improved imaging accuracy and efficiency, further fueling market growth. Moreover, collaborations between healthcare institutions and manufacturers to expand the accessibility of nuclear imaging facilities across different regions have also played a significant role in driving the market forward.
The nuclear imaging market in India has experienced growth due to advancements in medical imaging technology and increasing applications in diagnosis and treatment planning. However, the market faces challenges. One of the primary challenges is the high cost of nuclear imaging equipment and radiopharmaceuticals, making them expensive for certain healthcare facilities and patients. Access to trained personnel, including radiologists and nuclear medicine technologists, can also be a challenge, particularly in rural and underserved areas. Additionally, stringent regulations related to the handling and transportation of radioactive materials pose logistical and administrative challenges. Nuclear imaging equipment manufacturers and healthcare providers need to address these challenges by promoting awareness about the benefits of nuclear imaging, fostering skilled workforce development, and advocating for streamlined regulations to improve accessibility and affordability.
The India nuclear imaging market experienced significant challenges during the COVID-19 pandemic. With the focus on managing the pandemic, non-urgent medical imaging procedures, including nuclear imaging, were temporarily deferred in many healthcare facilities. This led to a decline in the adoption of nuclear imaging technologies. Additionally, the global disruptions in the supply chain and reduced international trade affected the import of nuclear imaging equipment and radiopharmaceuticals. However, the demand for nuclear imaging remained in critical applications, such as cancer diagnosis and treatment planning. As healthcare services resumed, the market started recovering, with increased emphasis on early diagnosis and disease management.
The India nuclear imaging market has been growing steadily with the increasing prevalence of cancer and cardiovascular diseases. Key players in this market include leading medical equipment companies like Siemens Healthineers, GE Healthcare, and Philips Healthcare, which offer a wide range of nuclear imaging systems such as SPECT (Single-Photon Emission Computed Tomography) and PET (Positron Emission Tomography) scanners. These companies collaborate with healthcare facilities and research institutions to provide cutting-edge nuclear imaging solutions for accurate diagnoses and treatment planning. Domestic players like Allengers Medical Systems also contribute to the market by offering more affordable nuclear imaging solutions tailored to the India healthcare market.